Ornithine decarboxylase activity during development of the mouse inner ear in vivo and in vitro by Crann, Sherry A. et al.




9 Springer-Verlag 1991 
Ornithine decarboxylase activity during development of the mouse 
inner ear in vivo and in vitro 
Sherry A. Crann 1, Thomas R. Van de Water 2, and Jochen Sehacht 1 
1 Kresge Hearing Research Institute, University of Michigan, Ann Arbor, MI 48109-0506, USA 
2 Department of Otolaryngology and Department of Neuroscience, Laboratory of Developmental Otobiology, Albert Einstein College 
of Medicine, Bronx, NY 10461, USA 
Accepted April 22, 1991 
Summary. Ornithine decarboxylase activity was deter- 
mined during the development of the peripheral auditory 
system in the murine otocyst with the goal of under- 
standing the role of this enzyme in the morphological 
and functional maturation of the inner ear. At gestation- 
al days 11 and 12 enzyme activity was more than 10-fold 
higher than adult levels. A sharp decline occured be- 
tween day 12 and 13 after which activity rose to a peak 
around day 15. Activity then dropped continuously until 
near-adult levels were reached at birth. A lower specific 
activity of ODC but a similar time-course was seen in 
otocysts explanted at gestational day 13 and subsequent- 
ly cultured for 6 days. For two stages of development, 
enzyme activity and binding of 3H-c~-difluoromethylor- 
nithine were compared. The four-fold difference in enzy- 
matic activity on gestational days ]5 and 17 was paral- 
leled by a similar difference in binding. Ornithine decar- 
boxylase activity during inner ear development therefore 
seems primarily regulated at the level of protein synthe- 
sis. Ornithine decarboxylase activity correlates with ma- 
jor inductive events in the morphogenesis of the cartila- 
genous otic capsule that serves as a template for the 
formation of the bony labyrinth. The pattern of activity 
may reflect the changes in the head mesenchyme that 
is recruited by the otocyst to aggregate and form its 
protective otic capsule. 
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Ornithine decarboxylase (ODC; EC 4.1.1.17) catalyzes 
the conversion of ornithine to putrescine, the rate limit- 
ing step in p01yamine synthesis. ODC activity is signifi- 
cantly higher in developing and regenerating tissues than 
in mature tissues, and the enzyme appears crucial to 
organ development and cellular repair in a number of 
systems (Fozard et al. ~980; Russell 1985). Polyamines 
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are important effectors of cellular mechanisms via DNA 
stabilization and synthesis (Hougaard and Larsson 1989; 
Slotkin et al. 1984), regulation of protein synthesis (Slot- 
kin et al. 1984) and of enzymes unrelated to polyamine 
pathways (Gilad and Gilad 1984), membrane stabiliza- 
tion (Ballas et al. 1983), and augmentation of receptor 
actions (Koenig et al. 1983). ODC activity is regulated 
by mechanisms which include feedback inhibition by po- 
lyamines (Pegg 1986), a protein inhibitor "antizyme" 
(Fong et al. 1976), phosphorylation (Atmar and Kuehn 
1981), and induction by gene amplification and in- 
creased rate of translation (Hougaard and Larsson 
1989). This high degree of regulation suggests a critical 
role for ODC and polyamines in cellular function. ODC 
is ubiquitous and we have previously shown it to be 
present in tissues of the inner ear (Henley et al. 1987). 
Hearing loss has been reported in patients receiving 
the antitumor agent ~-difiuoromethylornithine 
(DFMO), a specific inhibitor of ODC (Sjoerdsma and 
Schechter 1984), and DFMO-induced hearing loss has 
been confirmed in the guinea pig (Jansen et al. 1989). 
Postnatal changes of ODC and a critical period for 
DFMO ototoxicity have been observed in the developing 
pigmented rat (Henley et al. 1990). However, a role of 
ODC in the development and function of the inner ear 
has not been established yet. This study was designed 
to investigate ODC activity during the prenatal develop- 
ment of the peripheral auditory system of the mouse 
with the goal of understanding the role of this enzyme 
in the morphological and functional maturation of the 
inner ear. The murine otocyst was chosen as the develop- 
mental model because of the major morphogenetic 
changes it undergoes during embryonic development 
(Van De Water 1984). 
Materials and methods 
Tissue preparation 
CBA males were bred with C57B16 females to yield CBA/C57B16 
hybrid embryos. Timed pregnancies were obtained by the vaginal 
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plug method with the day of plug occurrence designated gestational 
day (gd) one. Actual embryonic age was determined by somite 
count until gd 13, thereafter by a combination of somite count 
and external features (Theiler 1972). 
Otocysts were excised from embryos of gd 11 through 18. Gra- 
vid mice were killed by cervical dislocation and the embryos re- 
moved and placed in Dulbecco's phosphate buffered saline (pH 
7.4) kept at 4 ~ The otocyst, surrounding periotic mesenchyme, 
and cochlear-vestibular ganglion complex (CVG) were excised 
from embryos of gd 11 through 13. The otic capsule is a defined 
entity by gd 14, and from this time on the cartilaginous capsule, 
membranous labyrinth and the CVG complex were extirpated as 
a unit. Each specimen was placed into an individual test tube, 
quick-frozen in liquid nitrogen and stored at - 70 ~ C. 
For otocyst cultures, explants from embryos of gd 13 were 
maintained in 35 mm plastic dishes containing 1 ml of Newman 
& Tytell Serumless Medium supplemented with J0% heat-inacti- 
vated fetal calf serum. Six samples were cultured per dish and 
medium was completely exchanged every 48 hours. The culture 
chamber was kept at 37 ~ saturated humidity and a gas composition 
of 5 % CO 2 in room air. Upon termination of culture, the specimens 
were briefly washed in PBS, quick-frozen and stored at - 7 0  ~ C 
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Fig. 1. ODC activity as a function of developmental stage. From 
each gestational day, three otocysts were assayed for ODC activity 
as described in "Materials and methods". ODC activity is ex- 
pressed as pmoles C02 formed x mg- ~ protein x h -z and values 
are means from duplicate analyses of individual otocyst. Otocysts 
were ranked by protein content within a given gestational day 
as discussed in "Results" 
ODC assays 
Single otocysts were homogenized by hand in a 200 p~l glass/glass 
homogenizer in 60 gl of 125 mM N-[2-hydroxyethyl] piperazine- 
N'-[2-ethanesulfonic acid] (HEPES), pH 7.2, 5 mM dithioerythritol 
(DTE), 0.25 mM ethylenediamine tetraacetate (EDTA), 125 gM 
pyridoxal 5-phosphate (PLP), and 10 gM phenylmethylsulfonyl 
fluoride. The homogenate was centrifuged at 12 500 g for 15 rain. 
An aliquot of the resulting supernatant was assayed for protein 
(Bradford 1976). Another aliquot was combined with half as much 
volume of 2 mg bovine serum albumin/ml (to stabilize protein) 
and assayed for enzyme activity. All manipulations prior to the 
enzyme assay were done at 4 ~ C. 
ODC was assayed by a modification of the procedure of Russell 
and Snyder (1968) as previously described (Henley et al. 1987). 
The supernatant fraction (1 to 12 gg of protein) was incubated 
at 37 ~ for 60 rain in closed incubation vessels in a total volume 
of 50 gl of (final concentrations) 50 mM HEPES, pH 7.2, 2 mM 
DTE, 0.1 mM EDTA, 0.2 mg BSA/gl, 50 ~M PLP, and 300 gM 
L-ornithine or DL-ornithine (L-[JJ4C] ornithine, 52.3 mCi/ 
mmole; DL- [ 1-14C] ornithine, 50.3 mCi/mmole; New England Nu- 
clear, Wilmington, Del., USA). Five hundred p~M of c~-difluoro- 
methyl-ornithine (DFMO; a gift from the Merrell Dow Research 
Institute, Cincinnati, Ohio, USA) was added to parallel incubations 
as a specific inhibitor of ODC. Incubations were terminated by 
the injection of 200 gl of 4 N t712SO 4 into the vessels and post- 
incubated for at least 45 rain at room temperature to trap the 
evolving COz on to filters previously wetted with 40% KOH. The 
filters were then removed from the reaction vials, the KOH was 
neutralized with acetic acid, and radioactivity determined by liquid 
scintillation counting. Duplicates were run of each condition and 
ODC activity was determined as that fraction of total CO2 pro- 
duced/hr/mg protein that was inhibited by DFMO. 
Binding studies with tritiated DFMO were performed under 
conditions similar to that of the ODC activity assay. Three to 
four otocysts were homogenized in 165 gl of buffer and centrifuged 
as above. An aliquot of the supernatant was assayed for protein, 
another for ODC activity, and a third was used for the binding 
assay. For the binding assay, the supernatant was combined with 
DL-c~-[3,4-3H]-DFMO (26.6 Ci/mmol; New England Nuclear, 
Wilmington, Del., USA) at a final concentration of 1.4 gM. The 
sample was incubated for 60 min at 37 ~ removed to ice for approxi- 
mately 5 min and then applied, at room temperature, to a column 
(4 mm x 25 cm) of Sephadex G-25-50 previously equilibrated with 
the assay buffer. Fractions of approximately 100 gl were collected, 
the protein-containing fractions were pooled and aliquots for total 
protein and radioactivity were taken. A second aliquot from the 
same supernatant was assayed for 3H-DFMO binding after prein- 
cubation at 37 ~ for 30 minutes with 500 gM unlabelled DFMO 
to correct for nonspecific binding. 
Results 
Three  aspects  o f  O D C  act iv i ty  were inves t iga ted :  (1) 
the t ime course  o f  O D C  act iv i ty  o f  the deve lop ing  inner  
ear ;  (2) the co r re l a t ion  o f  3 H - D F M O  b ind ing  wi th  O D C  
enzymat ic  ac t iv i ty ;  (3) the t ime course  o f  O D C  act iv i ty  
in o tocys t s  exp lan ted  at  gd J 3 and  cu l tu red  in vi t ro.  
ODC activity during development in vivo 
The act iv i ty  o f  O D C  in o tocys ts  changed  s ignif icant ly  
dur ing  d e v e l o p m e n t  o f  the inner  ear  (Fig.  l ) .  The  O D C  
act iv i ty  was expressed as enzymat i c  ac t iv i ty  per  mg  p ro -  
tein to correc t  for  changes  due to increase  in to ta l  o to-  
cyst  mass.  In  add i t ion ,  ind iv idua l  o tocys t s  were r anked  
by  p ro t e in  con ten t  or  weight  to con t ro l  for  the poss ib i l i ty  
tha t  o tocys t s  f rom a given " g e s t a t i o n a l  d a y "  inc luded  
specimens o f  s l ightly di f ferent  d e v e l o p m e n t  stages. Such 
a r ank ing  should  more  accura te ly  reflect subt le  and  dis- 
crete changes  dur ing  deve lopment .  However ,  c o m p a r i -  
son o f  the d a t a  revealed  tha t  the changes  in O D C  act iv i ty  
were evident  regardless  o f  the  n o r m a l i z a t i o n  p rocedure .  
F o r  c o m p a r i s o n  o f  O D C  in the  deve lop ing  o tocys t  
wi th  tha t  in the m a t u r e  cochlea ,  the  enzyme was ana-  
lyzed in cochlear  t issues o f  m a t u r e  44-day  o ld  mice. 
O D C  act iv i ty  was f o u n d  to be 134_+23 pmoles  CO2 
f o r m e d / m g  pro te in /h .  In  con t ras t ,  ac t iv i ty  in the devel-  
op ing  o to tcys t  (gd 11 and  12) was more  than  10-fold 
higher.  A sharp  decl ine in O D C  act iv i ty  occured  be tween  
day  12 and  13 af ter  which  act iv i ty  rose  to a peak  a r o u n d  
gd 15 (signif icance o f  difference be tween day  13 and  
15: 0 . 0 5 < P < 0 . 1 ) .  A t  this stage, ac t iv i ty  d r o p p e d  con-  
t inuous ly  unt i l  n e a r - a du l t  levels were reached  at  bir th .  
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Table 1. DFMO binding and ODC activity. DFMO binding and 
ODC activity were assayed on the same otocysts as described in 
"Materials and methods". Numbers are means-+ SD from three 
specimens for each gestational day 
Develop- DFMO binding ODC activity 
mental (dpm/mg (pmoles CO2 
stage protein) formed/h/mg 
protein) 
Ratio" 
Gd 15 36100_+5800 1508_+149 24 
Gd 17 8500-t-6000 423-+ 26 20 
" DFMO bound per unit of ODC activity 
1200 
1 0 0 0  
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Fig. 2. ODC activity in otocysts in vitro. Otocysts were explanted 
at gd 13 and specific activity of ODC was assayed as described 
in "Materials and methods". ODC activity is expressed as pmoles 
CO2 formed x mg- t protein x h- t and values are means_+ SD of 
triplicate determinations 
Binding of radiolabelled DFMO 
For two stages of development, aliquots of the enzyme 
fractions were assayed for binding of 3H-DFMO and 
ODC activity. Gestational days 15 and 17 were selected 
as they corresponded to a peak and a trough in enzymat- 
ic activity. The approximately four-fold difference in 
ODC activity was paralleled by a similar difference in 
the specific binding of 3H-DFMO (Table 1). 
ODC activity during development in vitro 
The third aspect of this study addressed the question 
whether the in vitro system reflected the pattern of ODC 
activity in vivo. Otocysts were explanted at gd 13 and 
cultured for 6 days (144 h). The specific activity of ODC 
dropped rapidly after the otocyst was explanted (Fig. 2) 
and rose to a peak after 48 h (significance, P<0.01). 
This time corresponds to the second division in vitro. 
At 144 h in vitro, ODC values were similar to those 
in otocysts in vivo at day 18 to 19. 
Discussion 
The time course of ODC activity shows a clear and dis- 
tinct pattern of peaks and troughs during development 
of the inner ear. Although more prominently displayed 
in vivo, activity changes are also present in the organ 
culture of the otocyst. The major questions arising from 
this first study of ODC in the developing inner ear are: 
(1) what mechanism(s) determine the time course of en- 
zymatic activity and (2) what aspects of development 
are controlled by ODC. 
Two mechanisms may account for the peaks and 
troughs in ODC activity during development: (1) 
changes in the amount of enzyme (due to induction of 
its synthesis); (2) variations in the activity of the enzyme 
due to inhibition by regulators such as a specific anti- 
zyme. The enzyme assay based on decarboxylation of 
ornithine determines the activity of ODC, whereas bind- 
ing of the specific inhibitor DFMO reflects the amount 
of ODC protein present. Thus, as the binding of DFMO 
parallels the peak and trough seen in the enzyme assays, 
the variation in ODC activity appears to be based upon 
varying concentrations of the enzyme. ODC activity dur- 
ing inner ear development therefore seems primarily re- 
gulated at the level of protein synthesis. 
The second question is more difficult to address and 
will require further detailed studies. During the period 
studied, tissue interactions modulate the developmental 
rates of both the epithelial and mesenchymal tissues that 
eventually form the membranous and bony labyrinths 
(McPhee and Van de Water 1986). There are also major 
shifts in the synthesis of matrix molecules that are in- 
volved in the formation of the cartilagenous otic capsule 
and the perilymphatic spaces (D'Amico-Martel et al. 
1987; McPhee and Van De Water 1985). A few correla- 
tions appear obvious. High ODC levels on day 11 corre- 
spond to high levels of cellular proliferation in the sur- 
rounding periotic mesenchyme which occurs just prior 
to the aggregation phase of otic capsule development 
between the 1 l th and 12th gd. On the 12th gd, during 
which ODC levels are still elevated, periotic mesenchyme 
is aggregated and an extracellular matrix is actively be- 
ing produced by the prechondrogenic mesenchyme 
(McPhee and Van De Water 1985; 1986). During gd 
13 a large subset of cells of the aggregated periotic mes- 
enchyme are involved in the formation of the perilym- 
phatic spaces (McPhee et al. 1987). This coincides with 
the decrease in ODC activity. Between days 14 and 16 
of gestation a mature cartilaginous capsule is produced 
coinciding with the peaks of ODC activity between ges- 
tation days 14 and 15. 
The ODC inhibitor DFMO in combination with the 
in vitro system should provide a valuable tool in the 
further elucidation of possible connections between 
ODC activity and specific features of otocyst morpho- 
genesis. Otocysts undergo morphogenesis in culture as 
they do in vivo, although some specific features such 
as tight junctions may not reach the same degree of 
maturity (Berggren et al. 1987). ODC levels in vitro re- 
flect the changes of enzyme activity in vivo. The precipi- 
tous drop of enzyme activity after explantation at gd 
13 is consistent with observations in other explanted or- 
gan systems (Huber and Brown 1982). Division 2 which 
corresponds to gd 15 in the in vivo development shows 
a clear peak of activity albeit of lower absolute activity 
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than  in vivo. I f  the app l i ca t i on  o f  D F M O  leads to dys-  
m or phogenes i s  a t  specific stages o f  deve lopment ,  corre-  
la t ions  m a y  be d r a w n  be tween  inh ib i t ion  o f  O D C  activi-  
ty and  the d i s rup t ion  o f  n o r m a l  m o r p h o g e n e t i c  expres-  
sion. A s imi lar  exper imen ta l  a p p r o a c h  using a p ro l ine  
an tagon i s t  was successful in s tudy ing  the role o f  p ro l ine  
synthesis  dur ing  d e v e l o p m e n t  o f  otic explan ts  (Van De 
Wate r  a n d  Ga l i nov i c -Schwar t z  1986). 
In  conclus ion ,  O D C  act iv i ty  appea r s  to cor re la te  wi th  
m a j o r  induct ive  events  in the morphogenes i s  a n d  fo rma-  
t ion o f  the  ca r t i l agenous  ot ic  capsule  tha t  serves as a 
t empla te  for  the f o r m a t i o n  o f  the b o n y  labyr in th .  O D C  
act iv i ty  m a y  reflect  the changes  in the head  mesenchyme  
tha t  is recrui ted  by  the o tocys t  to aggrega te  and  fo rm 
its p ro tec t ive  otic capsule .  
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